Microgenics Corporation

Click Here To EMAIL INQUIRY
Web: http://www.microgenics.com
E-Mail:
Address: 46360 Fremont Blvd., Fremont, California 94538, USA
Phone: +1-(510)-979-5000 | Fax: +1-(510)-979-5002 | Map/Directions >>

Profile: Microgenics Corporation manufactures and markets immunodiagnostic tests for drugs of abuse testing, therapeutic drug monitoring & calibration & linearity verification. We are accredited with ISO9001 and FDA certification. We offer products such as air quality instruments, bulk weighing, centrifugation, elemental analysis, chromatography, incubators & environmental chambers, life science reagents, heating instruments, flat sheet gauging & fluid handling. Our DRI® assays eliminate time-consuming steps in reagent preparation. We offer the Detect® line of specimen integrity tests that render timely and economical detection of urine adulteration.

The company has ~240 employees and is ISO 9001, CE certified.

FDA Registration Number: 3010939897

33 Products/Services (Click for related suppliers)

• Amphetamine Enzyme Immunoassay Test (FDA Code: DKZ / 862.3100)

An amphetamine test system is a device intended to measure amphetamine, a central nervous system stimulating drug, in plasma and urine. Measurements obtained by this device are used in the diagnosis and treatment of amphetamine use or overdose and in monitoring levels of amphetamine to ensure appropriate therapy.

• Barbiturate Enzyme Immunoassay Test (FDA Code: DIS / 862.3150)

A barbiturate test system is a device intended to measure barbiturates, a class of hypnotic and sedative drugs, in serum, urine, and gastric contents. Measurements obtained by this device are used in the diagnosis and treatment of barbiturate use or overdose and in monitoring levels of barbiturate to ensure appropriate therapy.

• Benzodiazepine Enzyme Immunoassay Test (FDA Code: JXM / 862.3170)

A benzodiazepine test system is a device intended to measure any of the benzodiazepine compounds, sedative and hypnotic drugs, in blood, plasma, and urine. The benzodiazepine compounds include chlordiazepoxide, diazepam, oxazepam, chlorzepate, flurazepam, and nitrazepam. Measurements obtained by this device are used in the diagnosis and treatment of benzodiazepine use or overdose and in monitoring levels of benzodiazepines to ensure appropriate therapy.

• Carbamazepine Enzyme Immunoassay Test (FDA Code: KLT / 862.3645)

A neuroleptic drugs radioceptor assay test system is a device intended to measure in serum or plasma the dopamine receptor blocking activity of neuroleptic drugs and their active metabolites. A neuroleptic drug has anti-psychotic action affecting principally psychomotor activity, is generally without hypnotic effects, and is a tranquilizer. Measurements obtained by this device are used to aid in determining whether a patient is taking the prescribed dosage level of such drugs.

• Controls for Diagnostic Equipment

• Digitoxin Enzyme Immunoassay Test (FDA Code: LFM / 862.3300)

A digitoxin test system is a device intended to measure digitoxin, a cardiovascular drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of digitoxin overdose and in monitoring levels of digitoxin to ensure appropriate therapy.

• Digoxin

• Digoxin Assay

• Digoxin Calibrators

• Digoxin Enzyme Immunoassay Test (FDA Code: KXT / 862.3320)

A digoxin test system is a device intended to measure digoxin, a cardiovascular drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of digoxin overdose and in monitoring levels of digoxin to ensure appropriate therapy.

• Digoxin, Enzyme Immunoassay

• Digoxin, Therapeutic Drug Monitoring Reagents

• Diphenylhydantoin Enzyme Immunoassay Test (FDA Code: DIP / 862.3350)

A diphenylhydantoin test system is a device intended to measure diphenylhydantoin, an antiepileptic drug, in human specimens. Measurements obtained by this device are used in the diagnosis and treatment of diphenylhydantoin overdose and in monitoring levels of diphenylhydantoin to ensure appropriate therapy.

• Drug Specific Control Test (FDA Code: LAS / 862.3280)

A clinical toxicology control material is a device intended to provide an estimation of the precision of a device test system and to detect and monitor systematic deviations from accuracy resulting from reagent or instrument defects. This generic type of device includes various single, and multi-analyte control materials.

• Drugs Of Abuse Test Kits

• Drugs Of Abuse Testing Kits

• Enzyme Immunoassay Test

• General Diagnostic Supplies

• Gentamicin Enzyme Immunoassay Test (FDA Code: LCD / 862.3450)

A gentamicin test system is a device intended to measure gentamicin, an antibiotic drug, in human specimens. Measurements obtained by this device are used in the diagnosis and treatment of gentamicin overdose and in monitoring levels of gentamicin to ensure appropriate therapy.

• Hormone Reagents & Test Kits

• Immunoassay Reagents & Test Kits

• Immunoassays

• Instruments, Immunoassays

• Methadone Enzyme Immunoassay Test (FDA Code: DJR / 862.3620)

A methadone test system is a device intended to measure methadone, an addictive narcotic pain-relieving drug, in serum and urine. Measurements obtained by this device are used in the diagnosis and treatment of methadone use or overdose and to determine compliance with regulations in methadone maintenance treatment.

• N-Acetylprocainamide Enzyme Immunoassay Test (FDA Code: LAN / 862.3320)

• Phencyclidine Enzyme Immunoassay (FDA Code: LCM)

• Phenobarbital Enzyme Immunoassay Test (FDA Code: DLZ / 862.3660)

A phenobarbitol test system is a device intended to measure phenobarbital, an antiepileptic and sedative-hypnotic drug, in human specimens. Measurements obtained by this device are used in the diagnosis and treatment of phenobarbital use or overdose and in monitoring levels of phenobarbital to ensure appropriate therapy.

• Phenytoin (Dilantin)

• Theophylline Enzyme Immunoassay Test (FDA Code: KLS / 862.3880)

A theophylline test system is a device intended to measure theophylline (a drug used for stimulation of the muscles in the cardiovascular, respiratory, and central nervous systems) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of theophylline overdose or in monitoring levels of theophylline to ensure appropriate therapy.

• Therapeutic Drugs Reagents & Test Kits

• Thyroid Uptake System

• Total Thyroxine Non-Radiolabeled Enzyme Immunoassay (FDA Code: KLI / 862.1700)

A total thyroxine test system is a device intended to measure total (free and protein bound) thyroxine (thyroid hormone) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of thyroid diseases.

• Valproic Acid Enzyme Immunoassay Test (FDA Code: LEG / 862.3645)